Oridonin inhibits gefitinib-resistant lung cancer cells by suppressing EGFR/ERK/MMP-12 and CIP2A/Akt signaling pathways

Xiangling Xiao(Hebei General Hospital), Ying Liu(Guiyang Medical University)
International Journal of Oncology
April 15, 2016
Cited by 63


Related Papers